In classic 21-OHD CAH, prenatal exposure to potent androgens such as testosterone and Δ4-androstenedione at critical stages of sexual differentiation virilizes the external genitalia of genetic females, often resulting in genital ambiguity at birth. The classic form is further divided into the simple virilizing form (~25% of individuals) and the salt-wasting form, in which aldosterone production is inadequate (≥75% of individuals). Newborns with salt-wasting CAH caused by 21-OHD CAH are at risk for life-threatening salt-wasting crises.
Individuals with the nonclassic form of 21-OHD CAH have only moderate enzyme deficiency and present postnatally with signs of hyperandrogenism; females with the nonclassic form are not virilized at birth.
Classic Simple Virilizing 21-OHD CAH
Excess adrenal androgen production in utero results in genital virilization at birth in 46,XX females. In affected females, the excess androgens result in varying degrees of enlargement of the clitoris, fusion of the labioscrotal folds, and formation of a urogenital sinus. Because anti-müllerian hormone (AMH) is not secreted, the müllerian ducts develop normally into a uterus and fallopian tubes in affected females. It is not possible to distinguish between simple virilizing classic 21-OHD CAH and salt-wasting classic 21-OHD CAH based solely on the degree of virilization of an affected female at birth.
After birth, both females and males with classic simple virilizing 21-OHD CAH who do not receive glucocorticoid replacement therapy develop signs of androgen excess such as precocious development of pubic and axillary hair, acne, rapid linear growth, and advanced bone age. Untreated males have progressive penile enlargement and small testes. Untreated females have clitoral enlargement, hirsutism, male pattern baldness, menstrual abnormalities, and reduced fertility.
The initial growth in the young child with untreated 21-OHD CAH is rapid; however, potential height is reduced and short adult stature results from premature epiphyseal fusion. Even if treatment with cortisol replacement therapy begins at an early age and secretion of excess adrenal androgens is controlled, individuals do not generally achieve the expected adult height. Bone age remains advanced compared to chronologic age.
Pubertal development. In boys and girls with proper glucocorticoid therapy and suppression of excessive adrenal androgen production, onset of puberty usually occurs at the appropriate chronological age. However, exceptions occur even among individuals in whom the disease is well controlled.
It should be noted that in some previously untreated children, the start of glucocorticoid replacement therapy triggers true precocious puberty. This central precocious puberty may occur when glucocorticoid treatment releases the hypothalamic pituitary axis from inhibition by estrogens derived from excess adrenal androgen secretion.
Fertility. For most females who are adequately treated, menses are normal after menarche and pregnancy is possible [Lo et al 1999]. Overall fertility rates, however, are reported to be low. Reported reasons include inadequate vaginal introitus leading to unsatisfactory intercourse, elevated androgens leading to ovarian dysfunction and psychosexual behaviors around gender identity and selection of sexual partner(s).
Males. In males, the main cause of subfertility is the presence of testicular adrenal rest tumors, which are thought to originate from aberrant adrenal tissue and to respond to treatment with glucocorticoids. Further, gonadotropic hypogonadism may result from suppression of LH secretion by the pituitary by excessive adrenal androgens and their aromatization product [Ogilvie et al 2006].
Adrenal medulla. In individuals with classic 21-OHD CAH, deficiency of cortisol also affects the development and functioning of the adrenal medulla, resulting in lower epinephrine and metanephrine concentrations than those found in unaffected individuals [Merke et al 2000].
Classic salt-wasting 21-OHD CAH. When the loss of 21-hydroxylase function is severe, adrenal aldosterone secretion is insufficient for sodium reabsorption by the distal renal tubules, resulting in salt wasting as well as cortisol deficiency and androgen excess. Infants with renal salt wasting have poor feeding, weight loss, failure to thrive, vomiting, dehydration, hypotension, hyponatremia, and hyperkalemic metabolic acidosis progressing to adrenal crisis (azotemia, vascular collapse, shock, and death). Adrenal crisis can occur as early as age one to four weeks.
Affected males who are not detected in a newborn screening program are at high risk for a salt-wasting adrenal crisis because their normal male genitalia do not alert medical professionals to their condition; they are often discharged from the hospital after birth without diagnosis and experience a salt-wasting crisis at home. Conversely, the ambiguous genitalia of females with the salt-wasting form usually prompts early diagnosis and treatment.
Nonclassic 21-OHD CAH. Nonclassic 21-OHD CAH may present at any time postnatally, with symptoms of androgen excess including acne, premature development of pubic hair, accelerated growth, advanced bone age, and as in classic 21-OHD CAH, reduced adult stature as a result of premature epiphyseal fusion.
Females with nonclassic 21-OHD CAH are born with normal genitalia; postnatal symptoms may include hirsutism, temporal baldness, delayed menarche, menstrual irregularities, and infertility. Among adult females with nonclassic 21-OHD CAH, about 60% present with hirsutism only, about 10% with hirsutism and menstrual disorder, and about 10% with menstrual disorder only. The fertility rate among untreated females is reported to be 50% [Pang 1997]. Many females with nonclassic 21-OHD CAH develop polycystic ovaries.
Males with nonclassic 21-OHD CAH may have early beard growth and an enlarged phallus with relatively small testes.
Mildly reduced synthesis of cortisol is not clinically significant in individuals with nonclassic 21-OHD CAH.
Gender role behavior. Prenatal androgen exposure in females with classic forms of 21-OHD CAH has a virilizing effect on the external genitalia and childhood behavior. Prenatal androgen exposure correlates with a decrease in self-reported femininity by adult females, but not an increase in self-reported masculinity by adult females [Long et al 2004].
Changes in childhood play behavior correlated with reduced female gender satisfaction and reduced heterosexual interest in adulthood. Affected adult females are more likely to have gender dysphoria, and experience less heterosexual interest and reduced satisfaction with the assignment to the female sex. In contrast, males with 21-OHD CAH do not show a general alteration in childhood play behavior, core gender identity, or sexual orientation [Hines et al 2004].
Pathogenesis. When the function of 21-hydroxylating cytochrome 450 is inadequate, the cortisol production pathway is blocked, leading to the accumulation of 17-hydroxyprogesterone (17-OHP). The excess 17-OHP is shunted into the intact androgen pathway, where the 17,20-lyase enzyme converts the 17-OHP to Δ4-androstenedione, which is converted into androgens. Since the mineralocorticoid pathway requires minimal 21-hydroxylase activity, mineralocorticoid deficiency (salt wasting) is a feature of the most severe form of the disease.
The lack of the steroid product impairs the negative feedback control of adrenocorticotropin (ACTH) secretion from the pituitary, leading to chronic stimulation of the adrenal cortex by ACTH, resulting in adrenal hyperplasia.